Eleni Karakike, Brendon P Scicluna, Maria Roumpoutsou, Ioannis Mitrou, Niki Karampela, Athanasios Karageorgos, Konstantinos Psaroulis, Eleni Massa, Achillefs Pitsoulis, Panagiotis Chaloulis, Evanthia Pappa, Irene T Schrijver, Frantzeska Frantzeskaki, Malvina Lada, Nicolas Dauby, David De Bels, Ioannis Floros, Souzana Anisoglou, Eleni Antoniadou, Maria Patrani, Glykeria Vlachogianni, Eleni Mouloudi, Anastasia Antoniadou, David Grimaldi, Thierry Roger, W Joost Wiersinga, Iraklis Tsangaris, Evangelos J. Giamarellos-Bourboulis

Critical Care 2022 Jun 18;26(1):183
DOI: 10.1186/s13054-022-04055-4

View article 🡇

Funding

The study was supported by the Hellenic Institute for the Study of Sepsis and by the Horizon2020 Marie Skłodowska-Curie International Training Network “the European Sepsis Academy” (grant number 676129—granted to the National and Kapodistrian University of Athens). The funders had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication.

Keywords: Cholesterol; Clarithromycin; Macrolides; Multiple organ dysfunction; Recurrence; Sepsis
Related Study: INCLASS